Advertisement
UK markets closed

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    83.40
    +0.04 (+0.05%)
     

  • GOLD FUTURES

    2,335.70
    -6.40 (-0.27%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,301.86
    -230.16 (-0.43%)
     

  • CMC Crypto 200

    1,426.91
    +12.15 (+0.86%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

BioNTech misses earnings expectations, stock falls

Yahoo Finance Video

Yahoo Finance Live's Brad Smith discusses how BioNTech stock is trading amid earnings.

Video transcript

BRAD SMITH: Before we head to break let's look at shares of BioNTech, ticker symbol BNTX. It's missed earnings on both the top and bottom lines. BioNTech, the company which partnered with Pfizer, to help develop the first COVID-19 vaccine approved for use in the United States, did say that they expect an uptick in demand during the fourth quarter of 2022, subject to regulatory approval. That includes approval on their Omicron-adapted vaccines, which should be ready for delivery as early as October.